drugset / Trial / NCT01057758

STATIN-VAP STATIN-VAP - STATINs and Ventilator-Associated Pneumonia

NCT01057758

Phase 3 Terminated 300 enrolled Assistance Publique Hopitaux De Marseille
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective is to assess the efficacy and safety of oral simvastatin in patients with a suspicion of ventilator-associated pneumonia (VAP). The hypothesis of this study is that simvastatin therapy will improve mortality in patients a suspicion of VAP.

Timeline

Start
2009-09
Primary completion
2013-01
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simvastatin Small molecule 60 mg Oral

Indications